환자 등록 소프트웨어 시장 : 등록 종류별, 소프트웨어 종류별, 기능별, 최종사용자별 - 세계 기회 분석과 산업 예측(2021-2031년)

The global patient registry software market was valued at $993.28 million in 2021, and is projected to reach $2,508.27 million by 2031, registering a CAGR of 9.7% from 2022 to 2031.

Patient registries have been defined as an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves a predetermined scientific, clinical, or policy purpose. A patient registry is a collection for one or more purposes of standardized information about a group of patients who share a condition or experience. Research institutions, academic clinical institutions, or individual research teams establish a registry system for the purpose of observational data collection that can be used for a specific research agenda.

Growth of the patient registry software market is driven by increase in the usage of electronic health records (EHRs), increase in prevalence of chronic diseases, rise in government support for healthcare, surge in geriatric population and increase in potential benefits of patient registry in  hospitals and research organizations. Furthermore, the increase in usage of the stored data for post-marketing surveillance and surge in government initiatives to build patient registries help increase the growth of the market. However, concerns related to the security and privacy of the data and dearth of skilled resources hinder the market growth. Conversely, increase in awareness regarding technologies is expected to create lucrative opportunities for the market.

The patient registry software market is segmented on the basis of registry type, software type, functionality, end user and region. On the basis of registry type, the market is divided into disease registry, health service registry and product registry. The disease registry segment is further segmented by type into cardiovascular registry, diabetes registry, cancer registry, rare disease registry and others. The product registry segment is further divided into medical device registry and drug registry. On the basis of software type, the market is classified into standalone and integrated. On the basis of functionality, the market is classified into population health management, health information exchange, patient care management, medical research and clinical studies and others. On the basis of end user, the market is classified into hospitals, government and third party organizations, pharma, biotech and medical device companies and others. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The key market players operating in this market include Allscripts healthcare solutions, Inc., Conduent Inc., Dacima Software Inc., Elekta Solutions AB, ImageTrend, Inc., IQVIA Holdings Inc., McKesson Corporation, MRO Corp. (FIGmd, Inc.), Open Text Corporation, Ordinal data, Inc., Premier, Inc, UnitedHealth Group Inc. (Optum Inc.).

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient registry software market analysis from 2021 to 2031 to identify the prevailing patient registry software market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the patient registry software market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global patient registry software market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Registry type

• Disease Registry
  • Type
  • Cardiovascular Registry
  • Diabetes Registry
  • Cancer Registry
  • Rare Disease Registry
  • Others
• Health Service Registry
• Product Registry
  • Type
  • Medical device Registry
  • Drug Registry

By Software type

• Standalone
• Integrated

By Functionality

• Population Health Management
• Health Information Exchange
• Patient Care Management
• Medical Research and Clinical Studies
• Others

By End User

• Hospitals
• Government and third party organizations
• Pharma, Biotech and Medical Device Companies
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest Of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest Of LAMEA
• Key Market Players
  • Conduent, Inc.
  • Dacima Software Inc.
  • Elekta AB (pub)
  • FIGmd, Inc.
  • IBM Corp
  • ImageTrend, Inc.
  • IQVIA Holdings
  • McKesson Corporation
  • OpenText Corporation
  • Optum, Inc.
  • Ordinal Data, Inc.
  • Premier, Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Disease Registry
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market analysis by country
  • 4.2.4 Disease Registry Patient Registry Software Market by Type
    • 4.2.4.1 Cardiovascular Registry Market size and forecast, by region
    • 4.2.4.2 Diabetes Registry Market size and forecast, by region
    • 4.2.4.3 Cancer Registry Market size and forecast, by region
    • 4.2.4.4 Rare Disease Registry Market size and forecast, by region
    • 4.2.4.5 Others Market size and forecast, by region
• 4.3 Health Service Registry
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market analysis by country
• 4.4 Product Registry
  • 4.4.1 Key market trends, growth factors and opportunities
  • 4.4.2 Market size and forecast, by region
  • 4.4.3 Market analysis by country
  • 4.4.4 Product Registry Patient Registry Software Market by Type
    • 4.4.4.1 Medical device Registry Market size and forecast, by region
    • 4.4.4.2 Drug Registry Market size and forecast, by region

CHAPTER 5: PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Standalone
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market analysis by country
• 5.3 Integrated
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market analysis by country

CHAPTER 6: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 Population Health Management
  • 6.2.1 Key market trends, growth factors and opportunities
  • 6.2.2 Market size and forecast, by region
  • 6.2.3 Market analysis by country
• 6.3 Health Information Exchange
  • 6.3.1 Key market trends, growth factors and opportunities
  • 6.3.2 Market size and forecast, by region
  • 6.3.3 Market analysis by country
• 6.4 Patient Care Management
  • 6.4.1 Key market trends, growth factors and opportunities
  • 6.4.2 Market size and forecast, by region
  • 6.4.3 Market analysis by country
• 6.5 Medical Research and Clinical Studies
  • 6.5.1 Key market trends, growth factors and opportunities
  • 6.5.2 Market size and forecast, by region
  • 6.5.3 Market analysis by country
• 6.6 Others
  • 6.6.1 Key market trends, growth factors and opportunities
  • 6.6.2 Market size and forecast, by region
  • 6.6.3 Market analysis by country

CHAPTER 7: PATIENT REGISTRY SOFTWARE MARKET, BY END USER

• 7.1 Overview
  • 7.1.1 Market size and forecast
• 7.2 Hospitals
  • 7.2.1 Key market trends, growth factors and opportunities
  • 7.2.2 Market size and forecast, by region
  • 7.2.3 Market analysis by country
• 7.3 Government and third party organizations
  • 7.3.1 Key market trends, growth factors and opportunities
  • 7.3.2 Market size and forecast, by region
  • 7.3.3 Market analysis by country
• 7.4 Pharma, Biotech and Medical Device Companies
  • 7.4.1 Key market trends, growth factors and opportunities
  • 7.4.2 Market size and forecast, by region
  • 7.4.3 Market analysis by country
• 7.5 Others
  • 7.5.1 Key market trends, growth factors and opportunities
  • 7.5.2 Market size and forecast, by region
  • 7.5.3 Market analysis by country

CHAPTER 8: PATIENT REGISTRY SOFTWARE MARKET, BY REGION

• 8.1 Overview
  • 8.1.1 Market size and forecast
• 8.2 North America
  • 8.2.1 Key trends and opportunities
  • 8.2.2 North America Market size and forecast, by Registry type
    • 8.2.2.1 North America Disease Registry Patient Registry Software Market by Type
    • 8.2.2.2 North America Product Registry Patient Registry Software Market by Type
  • 8.2.3 North America Market size and forecast, by Software type
  • 8.2.4 North America Market size and forecast, by Functionality
  • 8.2.5 North America Market size and forecast, by End User
  • 8.2.6 North America Market size and forecast, by country
    • 8.2.6.1 U.S.
    • 8.2.6.1.1 Market size and forecast, by Registry type
    • 8.2.6.1.2 Market size and forecast, by Software type
    • 8.2.6.1.3 Market size and forecast, by Functionality
    • 8.2.6.1.4 Market size and forecast, by End User
    • 8.2.6.2 Canada
    • 8.2.6.2.1 Market size and forecast, by Registry type
    • 8.2.6.2.2 Market size and forecast, by Software type
    • 8.2.6.2.3 Market size and forecast, by Functionality
    • 8.2.6.2.4 Market size and forecast, by End User
    • 8.2.6.3 Mexico
    • 8.2.6.3.1 Market size and forecast, by Registry type
    • 8.2.6.3.2 Market size and forecast, by Software type
    • 8.2.6.3.3 Market size and forecast, by Functionality
    • 8.2.6.3.4 Market size and forecast, by End User
• 8.3 Europe
  • 8.3.1 Key trends and opportunities
  • 8.3.2 Europe Market size and forecast, by Registry type
    • 8.3.2.1 Europe Disease Registry Patient Registry Software Market by Type
    • 8.3.2.2 Europe Product Registry Patient Registry Software Market by Type
  • 8.3.3 Europe Market size and forecast, by Software type
  • 8.3.4 Europe Market size and forecast, by Functionality
  • 8.3.5 Europe Market size and forecast, by End User
  • 8.3.6 Europe Market size and forecast, by country
    • 8.3.6.1 Germany
    • 8.3.6.1.1 Market size and forecast, by Registry type
    • 8.3.6.1.2 Market size and forecast, by Software type
    • 8.3.6.1.3 Market size and forecast, by Functionality
    • 8.3.6.1.4 Market size and forecast, by End User
    • 8.3.6.2 France
    • 8.3.6.2.1 Market size and forecast, by Registry type
    • 8.3.6.2.2 Market size and forecast, by Software type
    • 8.3.6.2.3 Market size and forecast, by Functionality
    • 8.3.6.2.4 Market size and forecast, by End User
    • 8.3.6.3 UK
    • 8.3.6.3.1 Market size and forecast, by Registry type
    • 8.3.6.3.2 Market size and forecast, by Software type
    • 8.3.6.3.3 Market size and forecast, by Functionality
    • 8.3.6.3.4 Market size and forecast, by End User
    • 8.3.6.4 Italy
    • 8.3.6.4.1 Market size and forecast, by Registry type
    • 8.3.6.4.2 Market size and forecast, by Software type
    • 8.3.6.4.3 Market size and forecast, by Functionality
    • 8.3.6.4.4 Market size and forecast, by End User
    • 8.3.6.5 Spain
    • 8.3.6.5.1 Market size and forecast, by Registry type
    • 8.3.6.5.2 Market size and forecast, by Software type
    • 8.3.6.5.3 Market size and forecast, by Functionality
    • 8.3.6.5.4 Market size and forecast, by End User
    • 8.3.6.6 Rest of Europe
    • 8.3.6.6.1 Market size and forecast, by Registry type
    • 8.3.6.6.2 Market size and forecast, by Software type
    • 8.3.6.6.3 Market size and forecast, by Functionality
    • 8.3.6.6.4 Market size and forecast, by End User
• 8.4 Asia-Pacific
  • 8.4.1 Key trends and opportunities
  • 8.4.2 Asia-Pacific Market size and forecast, by Registry type
    • 8.4.2.1 Asia-Pacific Disease Registry Patient Registry Software Market by Type
    • 8.4.2.2 Asia-Pacific Product Registry Patient Registry Software Market by Type
  • 8.4.3 Asia-Pacific Market size and forecast, by Software type
  • 8.4.4 Asia-Pacific Market size and forecast, by Functionality
  • 8.4.5 Asia-Pacific Market size and forecast, by End User
  • 8.4.6 Asia-Pacific Market size and forecast, by country
    • 8.4.6.1 Japan
    • 8.4.6.1.1 Market size and forecast, by Registry type
    • 8.4.6.1.2 Market size and forecast, by Software type
    • 8.4.6.1.3 Market size and forecast, by Functionality
    • 8.4.6.1.4 Market size and forecast, by End User
    • 8.4.6.2 China
    • 8.4.6.2.1 Market size and forecast, by Registry type
    • 8.4.6.2.2 Market size and forecast, by Software type
    • 8.4.6.2.3 Market size and forecast, by Functionality
    • 8.4.6.2.4 Market size and forecast, by End User
    • 8.4.6.3 Australia
    • 8.4.6.3.1 Market size and forecast, by Registry type
    • 8.4.6.3.2 Market size and forecast, by Software type
    • 8.4.6.3.3 Market size and forecast, by Functionality
    • 8.4.6.3.4 Market size and forecast, by End User
    • 8.4.6.4 India
    • 8.4.6.4.1 Market size and forecast, by Registry type
    • 8.4.6.4.2 Market size and forecast, by Software type
    • 8.4.6.4.3 Market size and forecast, by Functionality
    • 8.4.6.4.4 Market size and forecast, by End User
    • 8.4.6.5 South Korea
    • 8.4.6.5.1 Market size and forecast, by Registry type
    • 8.4.6.5.2 Market size and forecast, by Software type
    • 8.4.6.5.3 Market size and forecast, by Functionality
    • 8.4.6.5.4 Market size and forecast, by End User
    • 8.4.6.6 Rest of Asia-Pacific
    • 8.4.6.6.1 Market size and forecast, by Registry type
    • 8.4.6.6.2 Market size and forecast, by Software type
    • 8.4.6.6.3 Market size and forecast, by Functionality
    • 8.4.6.6.4 Market size and forecast, by End User
• 8.5 LAMEA
  • 8.5.1 Key trends and opportunities
  • 8.5.2 LAMEA Market size and forecast, by Registry type
    • 8.5.2.1 LAMEA Disease Registry Patient Registry Software Market by Type
    • 8.5.2.2 LAMEA Product Registry Patient Registry Software Market by Type
  • 8.5.3 LAMEA Market size and forecast, by Software type
  • 8.5.4 LAMEA Market size and forecast, by Functionality
  • 8.5.5 LAMEA Market size and forecast, by End User
  • 8.5.6 LAMEA Market size and forecast, by country
    • 8.5.6.1 Brazil
    • 8.5.6.1.1 Market size and forecast, by Registry type
    • 8.5.6.1.2 Market size and forecast, by Software type
    • 8.5.6.1.3 Market size and forecast, by Functionality
    • 8.5.6.1.4 Market size and forecast, by End User
    • 8.5.6.2 Saudi Arabia
    • 8.5.6.2.1 Market size and forecast, by Registry type
    • 8.5.6.2.2 Market size and forecast, by Software type
    • 8.5.6.2.3 Market size and forecast, by Functionality
    • 8.5.6.2.4 Market size and forecast, by End User
    • 8.5.6.3 South Africa
    • 8.5.6.3.1 Market size and forecast, by Registry type
    • 8.5.6.3.2 Market size and forecast, by Software type
    • 8.5.6.3.3 Market size and forecast, by Functionality
    • 8.5.6.3.4 Market size and forecast, by End User
    • 8.5.6.4 Rest of LAMEA
    • 8.5.6.4.1 Market size and forecast, by Registry type
    • 8.5.6.4.2 Market size and forecast, by Software type
    • 8.5.6.4.3 Market size and forecast, by Functionality
    • 8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE

• 9.1. Introduction
• 9.2. Top winning strategies
• 9.3. Product Mapping of Top 10 Player
• 9.4. Competitive Dashboard
• 9.5. Competitive Heatmap
• 9.6. Key developments

CHAPTER 10: COMPANY PROFILES

• 10.1 Conduent, Inc.
  • 10.1.1 Company overview
  • 10.1.2 Company snapshot
  • 10.1.3 Operating business segments
  • 10.1.4 Product portfolio
  • 10.1.5 Business performance
  • 10.1.6 Key strategic moves and developments
• 10.2 Dacima Software Inc.
  • 10.2.1 Company overview
  • 10.2.2 Company snapshot
  • 10.2.3 Operating business segments
  • 10.2.4 Product portfolio
  • 10.2.5 Business performance
  • 10.2.6 Key strategic moves and developments
• 10.3 Elekta AB (pub)
  • 10.3.1 Company overview
  • 10.3.2 Company snapshot
  • 10.3.3 Operating business segments
  • 10.3.4 Product portfolio
  • 10.3.5 Business performance
  • 10.3.6 Key strategic moves and developments
• 10.4 FIGmd, Inc.
  • 10.4.1 Company overview
  • 10.4.2 Company snapshot
  • 10.4.3 Operating business segments
  • 10.4.4 Product portfolio
  • 10.4.5 Business performance
  • 10.4.6 Key strategic moves and developments
• 10.5 IBM Corp
  • 10.5.1 Company overview
  • 10.5.2 Company snapshot
  • 10.5.3 Operating business segments
  • 10.5.4 Product portfolio
  • 10.5.5 Business performance
  • 10.5.6 Key strategic moves and developments
• 10.6 ImageTrend, Inc.
  • 10.6.1 Company overview
  • 10.6.2 Company snapshot
  • 10.6.3 Operating business segments
  • 10.6.4 Product portfolio
  • 10.6.5 Business performance
  • 10.6.6 Key strategic moves and developments
• 10.7 IQVIA Holdings
  • 10.7.1 Company overview
  • 10.7.2 Company snapshot
  • 10.7.3 Operating business segments
  • 10.7.4 Product portfolio
  • 10.7.5 Business performance
  • 10.7.6 Key strategic moves and developments
• 10.8 McKesson Corporation
  • 10.8.1 Company overview
  • 10.8.2 Company snapshot
  • 10.8.3 Operating business segments
  • 10.8.4 Product portfolio
  • 10.8.5 Business performance
  • 10.8.6 Key strategic moves and developments
• 10.9 OpenText Corporation
  • 10.9.1 Company overview
  • 10.9.2 Company snapshot
  • 10.9.3 Operating business segments
  • 10.9.4 Product portfolio
  • 10.9.5 Business performance
  • 10.9.6 Key strategic moves and developments
• 10.10 Optum, Inc.
  • 10.10.1 Company overview
  • 10.10.2 Company snapshot
  • 10.10.3 Operating business segments
  • 10.10.4 Product portfolio
  • 10.10.5 Business performance
  • 10.10.6 Key strategic moves and developments
• 10.11 Ordinal Data, Inc.
  • 10.11.1 Company overview
  • 10.11.2 Company snapshot
  • 10.11.3 Operating business segments
  • 10.11.4 Product portfolio
  • 10.11.5 Business performance
  • 10.11.6 Key strategic moves and developments
• 10.12 Premier, Inc.
  • 10.12.1 Company overview
  • 10.12.2 Company snapshot
  • 10.12.3 Operating business segments
  • 10.12.4 Product portfolio
  • 10.12.5 Business performance
  • 10.12.6 Key strategic moves and developments